Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

58.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.8K
RNA Editing02:23

RNA Editing

10.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.1K
Multiple Allele Traits01:49

Multiple Allele Traits

38.6K
The Concept of Multiple Allelism
38.6K
What is Genetic Engineering?00:49

What is Genetic Engineering?

81.1K
Overview
81.1K
Gene Families01:57

Gene Families

10.2K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.2K
Gene Therapy00:59

Gene Therapy

28.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Next-Gen Cell Therapy for Pediatric Patients: Neonatal Hepatocytes Tolerate Electroporation-Mediated Gene Editing and Engraft in the Liver.

The CRISPR journal·2026
Same author

High-power dual-channel chamber for high-frequency magnetic neuromodulation.

Journal of neural engineering·2026
Same author

High-Power Dual-Channel Chamber for High-Frequency Magnetic Neuromodulation.

bioRxiv : the preprint server for biology·2025
Same author

Generation of Region-specific Airway Basal Stem Cells from Human Pluripotent Stem Cells via Regulation of BMP-NOGGIN Axis.

bioRxiv : the preprint server for biology·2025
Same author

One Shock, Not One Cure: Electroporation Reveals Disease-Specific Constraints in Hepatocyte Gene Editing Therapy.

Biology·2025
Same author

Improving resolution with single-cell detection of CRISPR off-target events.

Molecular therapy. Methods & clinical development·2025

Related Experiment Video

Updated: Mar 19, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.5K

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

Renee N Cottle1, Ciaran M Lee2, Gang Bao3

  • 1Bioengineering Program, Clemson University and Medical University of South Carolina, Charleston, SC, 29425, USA.

Human Genetics
|June 18, 2016
PubMed
Summary

Gene therapy and genome editing offer new curative potential for hemoglobinopathies like sickle cell disease (SCD) and β-thalassemia. These advanced approaches aim to correct genetic mutations, overcoming limitations of current treatments.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

13.1K

Related Experiment Videos

Last Updated: Mar 19, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.5K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

13.1K

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Hemoglobinopathies, including sickle cell disease (SCD) and β-thalassemia, are genetic blood disorders causing significant global health issues.
  • Current treatments like transfusions and medications manage symptoms, while stem cell transplantation offers a cure but has limited accessibility.

Purpose of the Study:

  • To review the development and potential applications of gene therapy and genome editing for treating hemoglobinopathies.
  • To discuss the opportunities and challenges associated with advancing curative therapies for these genetic blood disorders.

Main Methods:

  • Review of existing literature on gene therapy strategies for hemoglobinopathies.
  • Analysis of nuclease-based gene correction techniques for precise mutation repair.
  • Discussion of safety considerations for gene therapy approaches.

Main Results:

  • Gene therapy using forced expression of β-globin variants shows promise but faces safety concerns.
  • Nuclease-based gene correction offers a novel approach to directly fix disease-causing mutations.
  • Both strategies aim to provide a curative rather than palliative treatment for hemoglobinopathies.

Conclusions:

  • Gene therapy and precision genome editing represent promising avenues for curative treatments for SCD and β-thalassemia.
  • Addressing safety concerns and optimizing delivery methods are crucial for clinical translation.
  • Further research and development are needed to overcome challenges and realize the full potential of these advanced therapies.